Literature DB >> 28044273

RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.

Minakshi Puzari1, Pankaj Chetia2.   

Abstract

Therapeutic failures against diseases due to resistant Gram-negative bacteria have become a major threat nowadays as confirmed by surveillance reports across the world. One of the methods of development of multidrug resistance in Escherichia coli and Pseudomonas aeruginosa is by means of RND efflux pumps. Inhibition of these pumps might help to combat the antibiotic resistance problem, for which the structure and regulation of the pumps have to be known. Moreover, judicious antibiotic use is needed to control the situation. This paper focuses on the issue of antibiotic resistance as well as the structure, regulation and inhibition of the efflux pumps present in Escherichia coli and Pseudomonas aeruginosa.

Entities:  

Keywords:  AcrAB–TolC; Efflux pump inhibition; MexAB–OprM; Multidrug resistance; RND efflux pumps

Mesh:

Substances:

Year:  2017        PMID: 28044273     DOI: 10.1007/s11274-016-2190-5

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  56 in total

Review 1.  The importance of efflux pumps in bacterial antibiotic resistance.

Authors:  M A Webber; L J V Piddock
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

Review 2.  Unmet medical needs in antibacterial therapy.

Authors:  Louis B Rice
Journal:  Biochem Pharmacol       Date:  2005-11-08       Impact factor: 5.858

3.  Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps.

Authors:  Jürgen A Bohnert; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 4.  Bacterial efflux pump inhibitors from natural sources.

Authors:  Michael Stavri; Laura J V Piddock; Simon Gibbons
Journal:  J Antimicrob Chemother       Date:  2006-12-04       Impact factor: 5.790

Review 5.  Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.

Authors:  Abdallah Mahamoud; Jacqueline Chevalier; Sandrine Alibert-Franco; Winfried V Kern; Jean-Marie Pagès
Journal:  J Antimicrob Chemother       Date:  2007-01-17       Impact factor: 5.790

Review 6.  Multidrug resistance in enteric and other gram-negative bacteria.

Authors:  A M George
Journal:  FEMS Microbiol Lett       Date:  1996-05-15       Impact factor: 2.742

Review 7.  Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria.

Authors:  M H Saier; I T Paulsen; M K Sliwinski; S S Pao; R A Skurray; H Nikaido
Journal:  FASEB J       Date:  1998-03       Impact factor: 5.191

8.  Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

9.  Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.

Authors:  Attilio V Vargiu; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-21       Impact factor: 11.205

Review 10.  Mechanisms of RND multidrug efflux pumps.

Authors:  Hiroshi Nikaido; Yumiko Takatsuka
Journal:  Biochim Biophys Acta       Date:  2008-11-03
View more
  13 in total

1.  Antibiotic Substrate Selectivity of Pseudomonas aeruginosa MexY and MexB Efflux Systems Is Determined by a Goldilocks Affinity.

Authors:  Debayan Dey; Logan G Kavanaugh; Graeme L Conn
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

Review 2.  Klebsiella oxytoca and Emerging Nosocomial Infections.

Authors:  Nakul Neog; Upasana Phukan; Minakshi Puzari; Mohan Sharma; Pankaj Chetia
Journal:  Curr Microbiol       Date:  2021-03-03       Impact factor: 2.188

3.  Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.

Authors:  E Batard; M-A Vibet; S Thibaut; S Corvec; J Pivette; D Lepelletier; J Caillon; E Montassier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-26       Impact factor: 3.267

4.  A palette of fluorophores that are differentially accumulated by wild-type and mutant strains of Escherichia coli: surrogate ligands for profiling bacterial membrane transporters.

Authors:  Jesus Enrique Salcedo-Sora; Srijan Jindal; Steve O'Hagan; Douglas B Kell
Journal:  Microbiology (Reading)       Date:  2021-02       Impact factor: 2.777

5.  Contribution of RaeB, a Putative RND-Type Transporter to Aminoglycoside and Detergent Resistance in Riemerella anatipestifer.

Authors:  Xin Zhang; Ming-Shu Wang; Ma-Feng Liu; De-Kang Zhu; Francis Biville; Ren-Yong Jia; Shun Chen; Kun-Feng Sun; Qiao Yang; Ying Wu; Xin-Xin Zhao; Xiao-Yue Chen; An-Chun Cheng
Journal:  Front Microbiol       Date:  2017-12-08       Impact factor: 5.640

Review 6.  Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.

Authors:  Chih-Hung Wang; Yi-Hsien Hsieh; Zachary M Powers; Cheng-Yen Kao
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

7.  Let-7b-5p in vesicles secreted by human airway cells reduces biofilm formation and increases antibiotic sensitivity of P. aeruginosa.

Authors:  Katja Koeppen; Amanda Nymon; Roxanna Barnaby; Laura Bashor; Zhongyou Li; Thomas H Hampton; Amanda E Liefeld; Fred W Kolling; Ian S LaCroix; Scott A Gerber; Deborah A Hogan; Swetha Kasetty; Carey D Nadell; Bruce A Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

8.  Xenon for tunnelling analysis of the efflux pump component OprN.

Authors:  Yvette Véronique Ntsogo Enguéné; Gilles Phan; Cyril Garnier; Arnaud Ducruix; Thierry Prangé; Isabelle Broutin
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

Review 9.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29

10.  Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.

Authors:  Julia Solnier; Liam Martin; Sanjib Bhakta; Franz Bucar
Journal:  Molecules       Date:  2020-02-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.